-based pharmaceutical firm Claris Lifesciences will buy-back shares aggregating 14.49 per cent of its total equity capital from shareholders for a total of Rs 231.25 crore. The company said it will buy-back up to 92.5 lakh shares of face value Rs 10 ... Business Standard India, 4 weeks ago
Claris to buy-back 14.49 per cent stake for Rs 231.25 crore - Economic Times, 4 weeks ago
Claris Lifesciences to buy back 14.5% shares through tender offer - PharmaBiz, 4 weeks ago
Claris Lifesiciences, a Rs. 650 crore pharmaceutical company from Ahmedabad, has posted consolidated net profit of Rs. 17.75 crore during the fourth quarter ended December 2013 from Rs. 25.19 crore in the corresponding period of last year. These ...PharmaBiz, 1 month ago
Naukri Job Speak Index for the month of February 14 reflects muted growth for the pharmaceutical sector. An month-over-month analysis reveals that index has grown by two per cent in February 2014 over January 2014. Yearly comparison shows a nine per ...Express Pharma, 1 month ago
This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for ...Digital Journal, 1 month ago
on your WebpageAdd Widget >Get your members hooked!